Abstract

An efficient immune response requires a selective and strong interaction of T cells with endothelium or target cells. These interactions are strengthened by the rapid induction of beta2-integrin-mediated adhesion upon chemokine receptor or T-cell receptor (TCR) stimulation, respectively. We and others have shown that an increase in G-alpha-s-protein coupled receptor (GalphasPCR) signaling, such as via beta2-adrenergic receptors counteracts chemokine-induced beta2-integrin activation and promotes de-adhesion and mobilization of effector CD8+ T cells from the marginal pool into the circulation. We asked whether GalphasPCR agonists also inhibit integrin activation induced by TCR stimulation of human antigen-specific T cells. Using soluble multimeric ICAM1-Fc-F(ab)2 fluorescent complexes, we developed a flow cytometry assay to identify integrin activation on virus-specific CD8+ T cells following short-term stimulation and staining with cytomegalovirus, Epstein–Barr virus, or influenza virus peptide-major histocompatibility complex class I HLA-multimers. From the GalphasPCR agonists used, epinephrine, norepinephrine, prostaglandins E2/D2 and adenosine strongly down-modulated the beta2-integrin activation on all virus-specific T cells and subsets of different stages of activation, while dopamine, serotonin and histamine had no effects. This active down-modulation of integrin activation through GalphasPCR signaling might be an essential mechanism by which the immune response is suppressed in a variety of pathologies characterized by increased levels of catecholamines (e.g., sleep deprivation), prostaglandins (e.g., tumor growth), or adenosine (e.g., hypoxia).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.